186 related articles for article (PubMed ID: 16354933)
1. Virally mediated increased neurotensin 1 receptor in the nucleus accumbens decreases behavioral effects of mesolimbic system activation.
Cáceda R; Kinkead B; Owens MJ; Nemeroff CB
J Neurosci; 2005 Dec; 25(50):11748-56. PubMed ID: 16354933
[TBL] [Abstract][Full Text] [Related]
2. Enhanced neurotensin neurotransmission is involved in the clinically relevant behavioral effects of antipsychotic drugs: evidence from animal models of sensorimotor gating.
Binder EB; Kinkead B; Owens MJ; Kilts CD; Nemeroff CB
J Neurosci; 2001 Jan; 21(2):601-8. PubMed ID: 11160439
[TBL] [Abstract][Full Text] [Related]
3. Biochemical and pharmacological activities of SR 142948A, a new potent neurotensin receptor antagonist.
Gully D; Labeeuw B; Boigegrain R; Oury-Donat F; Bachy A; Poncelet M; Steinberg R; Suaud-Chagny MF; Santucci V; Vita N; Pecceu F; Labbé-Jullié C; Kitabgi P; Soubrié P; Le Fur G; Maffrand JP
J Pharmacol Exp Ther; 1997 Feb; 280(2):802-12. PubMed ID: 9023294
[TBL] [Abstract][Full Text] [Related]
4. Sensorimotor gating in neurotensin-1 receptor null mice.
Feifel D; Pang Z; Shilling PD; Melendez G; Schreiber R; Button D
Neuropharmacology; 2010 Jan; 58(1):173-8. PubMed ID: 19596359
[TBL] [Abstract][Full Text] [Related]
5. The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion.
Cáceda R; Binder EB; Kinkead B; Nemeroff CB
Schizophr Res; 2012 Apr; 136(1-3):88-95. PubMed ID: 22104138
[TBL] [Abstract][Full Text] [Related]
6. The effects of intra-accumbens neurotensin on sensorimotor gating.
Feifel D; Minor KL; Dulawa S; Swerdlow NR
Brain Res; 1997 Jun; 760(1-2):80-4. PubMed ID: 9237521
[TBL] [Abstract][Full Text] [Related]
7. The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance.
Feifel D; Melendez G; Murray RJ; Tina Tran DN; Rullan MA; Shilling PD
Psychopharmacology (Berl); 2008 Oct; 200(2):197-203. PubMed ID: 18568338
[TBL] [Abstract][Full Text] [Related]
8. Repeated effects of the neurotensin receptor agonist PD149163 in three animal tests of antipsychotic activity: assessing for tolerance and cross-tolerance to clozapine.
Chou S; Davis C; Jones S; Li M
Pharmacol Biochem Behav; 2015 Jan; 128():78-88. PubMed ID: 25433325
[TBL] [Abstract][Full Text] [Related]
9. Characterization of binding sites of a new neurotensin receptor antagonist, [3H]SR 142948A, in the rat brain.
Betancur C; Canton M; Burgos A; Labeeuw B; Gully D; Rostène W; Pélaprat D
Eur J Pharmacol; 1998 Feb; 343(1):67-77. PubMed ID: 9551716
[TBL] [Abstract][Full Text] [Related]
10. Endogenous neurotensin down-regulates dopamine efflux in the nucleus accumbens as revealed by SR-142948A, a selective neurotensin receptor antagonist.
Brun P; Leonetti M; Sotty F; Steinberg R; Soubrié P; Renaud B; Suaud-Chagny MF
J Neurochem; 2001 Jun; 77(6):1542-52. PubMed ID: 11413237
[TBL] [Abstract][Full Text] [Related]
11. The effects of systemic NT69L, a neurotensin agonist, on baseline and drug-disrupted prepulse inhibition.
Shilling PD; Richelson E; Feifel D
Behav Brain Res; 2003 Jul; 143(1):7-14. PubMed ID: 12842291
[TBL] [Abstract][Full Text] [Related]
12. Sensorimotor gating in NTS1 and NTS2 null mice: effects of d-amphetamine, dizocilpine, clozapine and NT69L.
Oliveros A; Heckman MG; Del Pilar Corena-McLeod M; Williams K; Boules M; Richelson E
J Exp Biol; 2010 Dec; 213(Pt 24):4232-9. PubMed ID: 21113004
[TBL] [Abstract][Full Text] [Related]
13. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area.
Leonetti M; Brun P; Sotty F; Steinberg R; Soubrié P; Bert L; Renaud B; Suaud-Chagny MF
Naunyn Schmiedebergs Arch Pharmacol; 2002 Jun; 365(6):427-33. PubMed ID: 12070755
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of antipsychotic and psychotomimetic drugs on neurotensin systems of discrete extrapyramidal and limbic regions.
Gygi SP; Gibb JW; Hanson GR
J Pharmacol Exp Ther; 1994 Jul; 270(1):192-7. PubMed ID: 7913495
[TBL] [Abstract][Full Text] [Related]
15. Effects of chronic infusion of neurotensin and a neurotensin NT1 selective analogue PD149163 on amphetamine-induced hyperlocomotion.
Norman C; Beckett SR; Spicer CH; Ashton D; Langlois X; Bennett GW
J Psychopharmacol; 2008 May; 22(3):300-7. PubMed ID: 18208905
[TBL] [Abstract][Full Text] [Related]
16. Neurotensin in the nucleus accumbens reverses dopamine supersensitivity evoked by antipsychotic treatment.
Servonnet A; Minogianis EA; Bouchard C; Bédard AM; Lévesque D; Rompré PP; Samaha AN
Neuropharmacology; 2017 Sep; 123():10-21. PubMed ID: 28522313
[TBL] [Abstract][Full Text] [Related]
17. Repeated ventral midbrain neurotensin injections sensitize to amphetamine-induced locomotion and ERK activation: A role for NMDA receptors.
Voyer D; Lévesque D; Rompré PP
Neuropharmacology; 2017 Jan; 112(Pt A):150-163. PubMed ID: 27267684
[TBL] [Abstract][Full Text] [Related]
18. SR146131, a cholecystokinin-A receptor agonist, antagonizes prepulse inhibition deficits produced by dizocilpine and DOI.
Shilling PD; Feifel D
Psychopharmacology (Berl); 2002 Nov; 164(3):285-93. PubMed ID: 12424552
[TBL] [Abstract][Full Text] [Related]
19. Dopamine depletion of the nucleus accumbens reverses isolation-induced deficits in prepulse inhibition in rats.
Powell SB; Geyer MA; Preece MA; Pitcher LK; Reynolds GP; Swerdlow NR
Neuroscience; 2003; 119(1):233-40. PubMed ID: 12763084
[TBL] [Abstract][Full Text] [Related]
20. Pro-dopamine effects of neurotensin on sensorimotor gating deficits.
Feifel D; Reza TL; Robeck SL
Peptides; 1997; 18(9):1457-60. PubMed ID: 9392852
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]